Ray Dalio's BHC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 489,441 shares of Bausch Health Companies Inc. (BHC) worth $3.4 M, representing 0.01% of the portfolio. First purchased in 2017-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 307,068 shares. Largest reduction occurred in Q3 2025, reducing 308,010 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +52,888 | Add 12.11% | 489,441 | $6.95 |
| Q3 2025 | -308,010 | Reduce 41.37% | 436,553 | $6.45 |
| Q2 2025 | -64,417 | Reduce 7.96% | 744,563 | $6.66 |
| Q1 2025 | +307,068 | Add 61.18% | 808,980 | $6.47 |
| Q4 2024 | +267,089 | Add 113.74% | 501,912 | $8.06 |
| Q3 2024 | -12,953 | Reduce 5.23% | 234,823 | $8.16 |
| Q2 2024 | +177,251 | Add 251.33% | 247,776 | $6.97 |
| Q1 2024 | +15,302 | Add 27.71% | 70,525 | $10.61 |
| Q4 2023 | -34,939 | Reduce 38.75% | 55,223 | $8.06 |
| Q3 2023 | +2,474 | Add 2.82% | 90,162 | $8.27 |
| Q2 2023 | +12,481 | Add 16.60% | 87,688 | $8.01 |
| Q1 2023 | -9,158 | Reduce 10.86% | 75,207 | $8.09 |
| Q4 2022 | +6,442 | Add 8.27% | 84,365 | $6.27 |
| Q3 2022 | -13,385 | Reduce 14.66% | 77,923 | $6.94 |
| Q2 2022 | -167,367 | Reduce 64.70% | 91,308 | $8.35 |
| Q1 2022 | +113,430 | Add 78.10% | 258,675 | $22.87 |
| Q4 2021 | +59,478 | Add 69.35% | 145,245 | $27.66 |
| Q3 2021 | -29,530 | Reduce 25.61% | 85,767 | $27.88 |
| Q2 2021 | -4,529 | Reduce 3.78% | 115,297 | $29.38 |
| Q1 2021 | +41,012 | Add 52.04% | 119,826 | $31.72 |
| Q4 2020 | +78,814 | New Buy | 78,814 | $20.73 |
| Q2 2020 | -113,257 | Sold Out | 0 | $0.00 |
| Q1 2020 | -1,309 | Reduce 1.14% | 113,257 | $15.32 |
| Q4 2019 | -846 | Reduce 0.73% | 114,566 | $29.97 |
| Q1 2019 | -26,660 | Reduce 18.77% | 115,412 | $24.68 |
| Q4 2018 | -27,814 | Reduce 16.37% | 142,072 | $18.49 |
| Q3 2018 | +24,460 | Add 16.82% | 169,886 | $25.66 |
| Q2 2018 | +104,480 | Add 255.17% | 145,426 | $23.26 |
| Q1 2018 | -909 | Reduce 2.17% | 40,946 | $15.90 |
| Q4 2017 | -28,414 | Reduce 40.44% | 41,855 | $20.91 |
| Q2 2017 | +70,269 | New Buy | 70,269 | $17.36 |
Ray Dalio's Bausch Health Companies Investment FAQs
Ray Dalio first purchased Bausch Health Companies Inc. (BHC) in Q2 2017, acquiring 70,269 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Bausch Health Companies Inc. (BHC) for 34 quarters since Q2 2017.
Ray Dalio's largest addition to Bausch Health Companies Inc. (BHC) was in Q1 2025, adding 808,980 shares worth $5.23 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 489,441 shares of Bausch Health Companies Inc. (BHC), valued at approximately $3.4 M.
As of the Q4 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Bausch Health Companies Inc. (BHC) was 808,980 shares, as reported at the end of Q1 2025.